ArticleFrontiers in pharmacology2025
Gegen Qinlian decoction prevents post-ERCP pancreatitis by regulating NLRP3 inflammasome-mediated pyroptosis.
Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Harnessing early enzymatic biomarkers and cytokines for risk prediction in post-endoscopic retrograde cholangiopancreatography pancreatitis.World journal of gastroenterology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Post-ERCP pancreatitis (PEP) is a type of acute pancreatitis (AP) and the most common complication after ERCP. NLRP3 inflammasome-dependent pyroptosis is a key factor in the pathogenesis of acute pancreatitis. Gegen Qinglian decoction (GQD) is a traditional Chinese medicine formula that has the effects of clearing heat and detoxifying, and is now widely used in pancreatic diseases. We have clinically found that GQD can effectively prevent PEP. To explore its potential preventive mechanism, we conducted rat experiments. Methods: Before modeling, GQD, indomethacin suppository, NLRP3 inhibitor, etc. were used for intervention, and the GQD used was qualitatively analyzed by UPLC-QTOF-MS/MS. Then, a PEP model was established by injecting contrast medium into the pancreatic and bile ducts of rats, an Results: UPLC analysis of GQD identified 227 known metabolites. The expression of NLRP3, Caspase-1, and GSDMD in PEP model was significantly increased compared to the blank group, indicating the activation of NLRP3 inflammasome mediated cell pyroptosis during PEP occurrence. Prophylactic administration of GQD resulted in a reduction in the expression of NLRP3, Caspase-1, and GSDMD. Additionally, GQD significantly alleviated the pathological inflammation in the pancreas, and reduced levels of amylase and inflammatory cytokines. The GQD group, indomethacin suppository group, NLRP3 inhibitor group, and siRNA gene suppression group showed similar results. Conclusion: GQD can effectively prevent PEP, and its primary mechanism may be related to the regulation of NLRP3 inflammasome-mediated pyroptosis. Provide theoretical basis for the use of traditional Chinese medicine in clinical practice to prevent diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.